P5-PARK – A new target for parkinsonism based on a type 5 P-type ATPase

Scientists at the University of Cologne, Germany, have linked successfully a trans-membrane ATPase to the hereditary parkinsonism Kufor Rakeb syndrome PARK9. Loss of function mutations of P5-PARK were deemed to be causative for this autosomal recessive form of early-onset parkinsonism with pyramidal degeneration and dementia.

Analysis of P5-PARK sequence and/or expression will provide tools for diagnosis and therapy of hereditary neurodegenerative diseases like parkinsonism and dementia.

Further Information: PDF

PROvendis GmbH
Phone: +49 (0)208/94105 0

Contact
Dipl.-Ing. Alfred Schillert

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

All latest news from the category: Technology Offerings

Back to home

Comments (0)

Write a comment

Newest articles

Lighting up the future

New multidisciplinary research from the University of St Andrews could lead to more efficient televisions, computer screens and lighting. Researchers at the Organic Semiconductor Centre in the School of Physics and…

Researchers crack sugarcane’s complex genetic code

Sweet success: Scientists created a highly accurate reference genome for one of the most important modern crops and found a rare example of how genes confer disease resistance in plants….

Evolution of the most powerful ocean current on Earth

The Antarctic Circumpolar Current plays an important part in global overturning circulation, the exchange of heat and CO2 between the ocean and atmosphere, and the stability of Antarctica’s ice sheets….

Partners & Sponsors